Skip to Main Content

In The News

Quae cum essent dicta, discessimus. Quis suae urbis conservatorem Codrum, quis Erechthei filias non maxime laudat? Quod autem satis est.

SINGAPORE’S NEXT CHALLENGE: TURNING MOMENTUM INTO SUSTAINABLE GROWTH

January 29, 2024

ALLAY THERAPEUTICS: A SITE-SPECIFIC DRUG IMPLANT TREATS POSTSURGICAL PAIN

February 13, 2023

Peninsula startup is seeking $60M for its opioid-free crackdown on pain

May 13, 2021

A non-opioid pain startup believes it can top the bupivacaine market — and it’s thinking in terms of weeks, not days

May 13, 2021

In The News

SINGAPORE’S NEXT CHALLENGE: TURNING MOMENTUM INTO SUSTAINABLE GROWTH

BioCentury | January 29, 2024

ALLAY THERAPEUTICS: A SITE-SPECIFIC DRUG IMPLANT TREATS POSTSURGICAL PAIN

MedTech Strategist | February 13, 2023

Peninsula startup is seeking $60M for its opioid-free crackdown on pain

San Francisco Business Times | May 13, 2021

A non-opioid pain startup believes it can top the bupivacaine market — and it’s thinking in terms of weeks, not days

Endpoints | May 13, 2021

Presentations and Publications

ATX101 Provided Sustained Pain Relief in TKA Patients: Results of an Exploratory Multicenter Double-Blind RCT

AAHKS | November 7, 2024